10/19/2026
How science starts: Someone notices something.
A woman starts testosterone. A few months in, she says, “Weird thing. My asthma is better. I’m barely using my inhaler.”
A clinician pays attention.
That observation becomes a question.
Could testosterone affect the airways?
The question sends researchers looking for a mechanism.
And here’s the fun part: before puberty, asthma is more common in boys. After puberty, it flips, and it’s more common in women. Lab and animal studies suggest androgens calm some of the immune cells that drive allergic airway inflammation.
So is testosterone an asthma treatment?
Not yet.
The strongest signals come from population data and mechanism studies, plus a handful of small androgen trials. Direct clinical trials of testosterone for asthma? They don’t exist. The one large real-world cohort showed effects that were modest, delayed, and complicated.
Which is exactly the point. That gap is where the next trial lives.
Observation → question → mechanism → trial.
Now, notice where it starts.
It doesn’t start in a lab. It starts with a person describing her own body. And for decades, when that person was a woman, the first step got skipped. “It’s a coincidence.” “It’s in your head.” “Your labs are normal.”
Dismiss the observation and you never get the question. No question, no mechanism. No mechanism, no trial. No trial? Then “there’s no evidence,” and the dismissal looks justified. Convenient.
So hear me clearly:
Your voice matters.
Your firsthand experience matters.
You are not an anecdote. You are data that hasn’t been collected yet.
Keep talking. Keep writing it down. Keep telling your doctor.
That’s how science starts.